Trump signs order to streamline U.S. drug manufacturing regulations, aiming to encourage more domestic production and reduce reliance on foreign imports.
Investors seek opportunities in small-cap and penny stocks globally, with varying financial profiles and prospects.
Trump signs order to streamline U.S. drug manufacturing regulations, aiming to encourage more domestic production and reduce reliance on foreign imports.
Investors seek opportunities in small-cap and penny stocks globally, with varying financial profiles and prospects.
